NeOnc to Expand Abu Dhabi Research and Schedule FDA Meeting in November
NTHI NeOnc Technologies Holdings Inc
$2.77 +1.84%
View chart & analysis → - 1NeOnc Technologies Holdings, Inc. is expanding research opportunities in collaboration with the Abu Dhabi Department of Health.
- 2As of September 30, NTHI short interest of 757,739 shares increased by approximately 45% compared to the 522,311 shares on September 15.
- 3NeOnc Technologies Holdings, Inc. is scheduled to hold a face-to-face meeting with the FDA on November 17, 2026.
So what's the key point?
NeOnc Technologies Holdings, Inc. is expanding research with the Abu Dhabi Department of Health and meeting with the US FDA. The amount of shares being sold short has increased to 757,739 shares.
Source Newsfile Corp. +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.